ARTL Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Artelo Biosciences Inc (ARTL) is not a good buy for a beginner investor with a long-term strategy at this time. The stock shows bearish technical indicators, no significant positive catalysts, and weak financial performance. Given the lack of strong trading signals or positive sentiment, holding off on investing in this stock is recommended.
The technical indicators for ARTL are bearish. The MACD is below 0 and negatively contracting, the RSI is neutral at 42.902, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below the pivot level of 1.254, with key support at 1.082 and resistance at 1.426.
NULL identified. No recent news or significant trading trends from hedge funds or insiders.
Bearish technical indicators, weak financial performance, and no recent news or trading activity to suggest a positive outlook.
In Q4 2025, the company's revenue remained at 0 with no YoY growth. Net income improved slightly to -4,166,000 (up 10.27% YoY), but EPS dropped significantly by -70.44% YoY to -2.06. Gross margin remained at 0.
No analyst rating or price target changes available.
